156 related articles for article (PubMed ID: 38243010)
1. Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
Heymer EJ; Hawkins MM; Winter DL; Teepen JC; Sunguc C; Ronckers CM; Allodji RS; Alessi D; Sugden E; Belle FN; Bagnasco F; Byrne J; Bárdi E; Garwicz S; Grabow D; Jankovic M; Kaatsch P; Kaiser M; Michel G; Schindera C; Haddy N; Journy N; Česen Mazić M; Skinner R; Kok JL; Gunnes MW; Wiebe T; Sacerdote C; Maule MM; Terenziani M; Jakab Z; Winther JF; Lähteenmäki PM; Zadravec Zaletel L; Haupt R; Kuehni CE; Kremer LC; de Vathaire F; Hjorth L; Reulen RC
Br J Cancer; 2024 Apr; 130(6):976-986. PubMed ID: 38243010
[TBL] [Abstract][Full Text] [Related]
2. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
Neglia JP; Robison LL; Stovall M; Liu Y; Packer RJ; Hammond S; Yasui Y; Kasper CE; Mertens AC; Donaldson SS; Meadows AT; Inskip PD
J Natl Cancer Inst; 2006 Nov; 98(21):1528-37. PubMed ID: 17077355
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study.
Patterson BC; Chen Y; Sklar CA; Neglia J; Yasui Y; Mertens A; Armstrong GT; Meadows A; Stovall M; Robison LL; Meacham LR
J Clin Endocrinol Metab; 2014 Jun; 99(6):2030-7. PubMed ID: 24606096
[TBL] [Abstract][Full Text] [Related]
4. Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study.
Dudley IM; Sunguc C; Heymer EJ; Winter DL; Teepen JC; Belle FN; Bárdi E; Bagnasco F; Gudmundsdottir T; Skinner R; Michel G; Byrne J; Øfstaas H; Jankovic M; Mazić MČ; Mader L; Loonen J; Garwicz S; Wiebe T; Alessi D; Allodji RS; Haddy N; Grabow D; Kaatsch P; Kaiser M; Maule MM; Jakab Z; Gunnes MW; Terenziani M; Zaletel LZ; Kuehni CE; Haupt R; de Vathaire F; Kremer LC; Lähteenmäki PM; Winther JF; Hjorth L; Hawkins MM; Reulen RC
Cancer; 2023 Feb; 129(3):426-440. PubMed ID: 36444554
[TBL] [Abstract][Full Text] [Related]
5. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup.
Allodji RS; Hawkins MM; Bright CJ; Fidler-Benaoudia MM; Winter DL; Alessi D; Fresneau B; Journy N; Morsellino V; Bárdi E; Bautz A; Byrne J; Feijen ELA; Teepen JC; Vu-Bezin G; Rubino C; Garwicz S; Grabow D; Gudmundsdottir T; Guha J; Hau EM; Jankovic M; Kaatsch P; Kaiser M; Linge H; Muraca M; Llanas D; Veres C; Øfstaas H; Diallo I; Mansouri I; Ronckers CM; Skinner R; Terenziani M; Wesenberg F; Wiebe T; Sacerdote C; Jakab Z; Haupt R; Lähteenmäki P; Zaletel LZ; Kuehni CE; Winther JF; Michel G; Kremer LCM; Hjorth L; Haddy N; de Vathaire F; Reulen RC
Eur J Cancer; 2019 Aug; 117():71-83. PubMed ID: 31260818
[TBL] [Abstract][Full Text] [Related]
6. Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
Sunguc C; Hawkins MM; Winter DL; Dudley IM; Heymer EJ; Teepen JC; Allodji RS; Belle FN; Bagnasco F; Byrne J; Bárdi E; Ronckers CM; Haddy N; Gudmundsdottir T; Garwicz S; Jankovic M; van der Pal HJH; Mazić MČ; Schindera C; Grabow D; Maule MM; Kaatsch P; Kaiser M; Fresneau B; Michel G; Skinner R; Wiebe T; Sacerdote C; Jakab Z; Gunnes MW; Terenziani M; Winther JF; Lähteenmäki PM; Zaletel LZ; Kuehni CE; Kremer LC; Haupt R; de Vathaire F; Hjorth L; Reulen RC
Br J Cancer; 2023 Jan; 128(1):80-90. PubMed ID: 36319851
[TBL] [Abstract][Full Text] [Related]
7. Population-based risks of CNS tumors in survivors of childhood cancer: the British Childhood Cancer Survivor Study.
Taylor AJ; Little MP; Winter DL; Sugden E; Ellison DW; Stiller CA; Stovall M; Frobisher C; Lancashire ER; Reulen RC; Hawkins MM
J Clin Oncol; 2010 Dec; 28(36):5287-93. PubMed ID: 21079138
[TBL] [Abstract][Full Text] [Related]
8. Morbidity and Mortality Associated With Meningioma After Cranial Radiotherapy: A Report From the Childhood Cancer Survivor Study.
Bowers DC; Moskowitz CS; Chou JF; Mazewski CM; Neglia JP; Armstrong GT; Leisenring WM; Robison LL; Oeffinger KC
J Clin Oncol; 2017 May; 35(14):1570-1576. PubMed ID: 28339329
[TBL] [Abstract][Full Text] [Related]
9. Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Whitton JA; Friedman DL; Hammond S; Armstrong GT; Leisenring W; Robison LL; Neglia JP
J Clin Oncol; 2015 Nov; 33(31):3568-75. PubMed ID: 26261260
[TBL] [Abstract][Full Text] [Related]
10. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.
Friedman DL; Whitton J; Leisenring W; Mertens AC; Hammond S; Stovall M; Donaldson SS; Meadows AT; Robison LL; Neglia JP
J Natl Cancer Inst; 2010 Jul; 102(14):1083-95. PubMed ID: 20634481
[TBL] [Abstract][Full Text] [Related]
11. Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort.
Swerdlow AJ; Cooke R; Beckers D; Butler G; Carel JC; Cianfarani S; Clayton P; Coste J; Deodati A; Ecosse E; Hokken-Koelega ACS; Khan AJ; Kiess W; Kuehni CE; Flück CE; Pfaffle R; Sävendahl L; Sommer G; Thomas M; Tidblad A; Tollerfield S; Zandwijken GRJ
J Clin Endocrinol Metab; 2019 Mar; 104(3):658-664. PubMed ID: 30137467
[TBL] [Abstract][Full Text] [Related]
12. High incidence of meningioma in cranial irradiated survivors of childhood acute lymphoblastic leukemia.
Goshen Y; Stark B; Kornreich L; Michowiz S; Feinmesser M; Yaniv I
Pediatr Blood Cancer; 2007 Sep; 49(3):294-7. PubMed ID: 17243137
[TBL] [Abstract][Full Text] [Related]
13. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
[TBL] [Abstract][Full Text] [Related]
14. Trends in treatment of childhood cancer and subsequent primary neoplasm risk.
Cesen Mazic M; Reulen RC; Jazbec J; Zadravec Zaletel L
Radiol Oncol; 2022 Aug; 56(3):380-389. PubMed ID: 35848608
[TBL] [Abstract][Full Text] [Related]
15. Risk of second malignant neoplasms after childhood central nervous system malignant tumours: an international study.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Pukkala E; Weiderpass E; Olsen JH; Tracey E; McBride ML; Brewster DH; Pompe-Kirn V; Tonita JM; Kliewer EV; Chia KS; Jonasson JG; Martos C; Magnani C; Boffetta P
Eur J Cancer; 2008 Apr; 44(6):830-9. PubMed ID: 18329873
[TBL] [Abstract][Full Text] [Related]
16. Subsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapy.
Tsui K; Gajjar A; Li C; Srivastava D; Broniscer A; Wetmore C; Kun LE; Merchant TE; Ellison DW; Orr BA; Boop FA; Klimo P; Ross J; Robison LL; Armstrong GT
Neuro Oncol; 2015 Mar; 17(3):448-56. PubMed ID: 25395462
[TBL] [Abstract][Full Text] [Related]
17. [Secondary tumors following radiation therapy and chemotherapy : Incidence of cavernous hemangiomas].
Reith W; Yilmaz U
Radiologie (Heidelb); 2023 Aug; 63(8):603-608. PubMed ID: 37432425
[TBL] [Abstract][Full Text] [Related]
18. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.
Meadows AT; Friedman DL; Neglia JP; Mertens AC; Donaldson SS; Stovall M; Hammond S; Yasui Y; Inskip PD
J Clin Oncol; 2009 May; 27(14):2356-62. PubMed ID: 19255307
[TBL] [Abstract][Full Text] [Related]
19. Meningiomas after cranial radiotherapy for childhood cancer: a single institution experience.
Felicetti F; Fortunati N; Garbossa D; Biasin E; Rudà R; Daniele D; Arvat E; Corrias A; Fagioli F; Brignardello E
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1277-82. PubMed ID: 25609074
[TBL] [Abstract][Full Text] [Related]
20. Risk of Subsequent Neoplasms in Childhood Cancer Survivors After Radiation Therapy: A PENTEC Comprehensive Review.
Casey DL; Vogelius IR; Brodin NP; Roberts KB; Avanzo M; Moni J; Owens C; Ronckers CM; Constine LS; Bentzen SM; Olch A
Int J Radiat Oncol Biol Phys; 2024 Jun; 119(2):640-654. PubMed ID: 37777927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
